NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Nike Shares Plummet 14.5% Amid Gloomy Outlook and China Sales Decline

Nike, the sportswear giant, faced severe selling pressure on Wednesday, 1 April, as its shares plummeted 14.5% to an intraday low of $45.19. This marked the lowest level since October 2014. The decline in investor sentiment was largely due to the company's surprisingly gloomy outlook for current-quarter sales and slower-than-expected progress in its turnaround.

Elliott Hill, Nike's Chief Executive Officer, warned of another setback in one of its most critical markets. The company has seen sales decline in China for seven consecutive quarters, with the current quarter, ending 31 May, expected to be even worse. Nike is projecting a decline of up to 20% in the quarter.

CompanySales Growth (2025)
Anta13% to $11.6 billion
Li NingN/A
NikeDecline in China, flat revenue in Q3

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

The sportswear division was another area of concern in the third quarter, with high levels of discounting. The segment recorded double-digit declines. Overall, the company expects revenue to decline 2% to 4%, weaker than Wall Street's view for growth of about 2%. Gains in North America are expected to be offset by weakness in Greater China, with earnings remaining flat.

The ongoing conflict in the Middle East has further complicated the company's turnaround plans, while the retailer continues to struggle to regain traction in China amid intense competition from domestic upstart brands. China used to be one of Nike's biggest growth engines.

On the earnings call, Chief Financial Officer Matthew Friend said the conflict in the Middle East had already disrupted shopping behavior in parts of Europe, the Middle East, and Africa, leading to softer store traffic and weaker sportswear sales.

Nike reported third-quarter results on Tuesday that beat estimates despite continued weakness in its China business and steep declines at Converse. The company reported adjusted earnings per share of $0.35, beating Wall Street analyst estimates of $0.31. Revenue of $11.3 billion was flat year over year, primarily due to declines in EMEA and Greater China, partially offset by growth in North America.

Read also: MarketSmith India's 4 June Stock Recommendations

Nike Q3 Earnings (2026)Q3 (2025)Change
Adjusted Earnings Per Share$0.35$0.31
Revenue$11.3 billion$11.3 billion
Net Income$520 million$794 million
Diluted Earnings Per Share$0.35$0.54

Net sales in the period tallied $11.3 billion, flat from $11.3 billion on a reported basis and down 3% on a currency-neutral basis. Net income at the Beaverton, Oregon-based company in the third quarter of fiscal 2026 fell 35% to $520 million from $794 million in the year-ago period. Diluted earnings per share dropped to 35 cents from 54 cents.

Investor Takeaway

Investors should be cautious of Nike's weak sales outlook and China challenges.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.